Oslo, Norway

Sergej Michailovic Kiprijanov


Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014-2019

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Sergej Michailovic Kiprijanov

Introduction

Sergej Michailovic Kiprijanov is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of medical science, particularly through his innovative work on antibodies. With a total of four patents to his name, Kiprijanov's inventions have the potential to impact therapeutic and diagnostic applications.

Latest Patents

Kiprijanov's latest patents include groundbreaking inventions related to antibodies that bind to the human CC chemokine receptor 4 (CCR4). One of his patents describes antibodies capable of inhibiting the binding of macrophage-derived chemokine (MDC) and thymus and activation regulated chemokine (TARC) to CCR4. This invention also encompasses immunoconjugates and compositions that utilize these antibodies, particularly in medical and diagnostic fields. Another patent focuses on nucleic acid molecules encoding antibodies that bind to CCR4, further emphasizing their potential applications in healthcare.

Career Highlights

Throughout his career, Kiprijanov has worked with various organizations, including Affitech Research AS and Cancer Research Technology Limited. His work in these companies has allowed him to develop and refine his innovative ideas, contributing to advancements in medical research.

Collaborations

Kiprijanov has collaborated with notable professionals in his field, including Urs Beat Hagemann and Remko Griep. These collaborations have likely enriched his research and expanded the scope of his inventions.

Conclusion

Sergej Michailovic Kiprijanov is a distinguished inventor whose work on antibodies has the potential to revolutionize medical diagnostics and treatments. His contributions to the field are marked by his innovative patents and collaborations with other experts.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…